Rubin Michael P.

CIK 00018676276 companiesBETHESDA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001867627

Recent Transactions

35 trades

Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+1,003,193→ 1,003,193 total
Conversion
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15+471,415→ 471,415 total
Purchase
Camp4 Therapeutics Corp$CAMP
Common Stock
2024-10-15$11.00/sh+763,636→ 763,636 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series A Prime Preferred Stock
2024-10-15−11,251,624→ 0 total
Conversion
Camp4 Therapeutics Corp$CAMP
Series B Preferred Stock
2024-10-15−5,287,303→ 0 total
Purchase
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2024-02-12$22.00/sh+450,000→ 450,000 total
Conversion
Kyverna Therapeutics, Inc.$KYTX
Common Stock
2024-02-12+2,805,426→ 2,805,426 total
Conversion
Kyverna Therapeutics, Inc.$KYTX
Series B Preferred Stock
2024-02-12−12,767,776→ 0 total
Sale
DICE Therapeutics, Inc.
Common Stock
2023-06-22$46.50/sh−523,503→ 166,293 total
Sale
DICE Therapeutics, Inc.
Common Stock
2023-06-22$46.50/sh−1,969,368→ 633,707 total
Award
Telesis Bio Inc.
Short-Term Warrants
2023-06-05+1,692,549→ 1,692,549 total
Award
Telesis Bio Inc.
Long-Term Warrants
2023-06-05+3,385,097→ 3,385,097 total
Award
Telesis Bio Inc.
Redeemable Convertible Preferred Stock
2023-06-05$100.00/sh+80,000→ 3,385,097 total
Conversion
Vigil Neuroscience, Inc.
Series A Preferred Stock
2022-01-11−2,831,520→ 0 total
Conversion
Vigil Neuroscience, Inc.
Common Stock
2022-01-11+2,831,520→ 2,831,520 total
Purchase
Vigil Neuroscience, Inc.
Common Stock
2022-01-11$14.00/sh+355,000→ 1,382,978 total
Conversion
Vigil Neuroscience, Inc.
Common Stock
2022-01-11+1,027,978→ 1,027,978 total
Conversion
Vigil Neuroscience, Inc.
Series B Preferred Stock
2022-01-11−1,027,978→ 0 total
Conversion
IsoPlexis Corp
Series D Redeemable Convertible Preferred Stock
2021-10-12−130,006→ 0 total
Conversion
IsoPlexis Corp
Series C-2 Redeemable Convertible Preferred Stock
2021-10-12−309,131→ 0 total
Conversion
IsoPlexis Corp
Series C Redeemable Convertible Preferred Stock
2021-10-12−287,785→ 0 total
Conversion
IsoPlexis Corp
Series D Redeemable Convertible Preferred Stock
2021-10-12−191,108→ 0 total
Purchase
IsoPlexis Corp
Common Stock
2021-10-12$15.00/sh+1,000,000→ 2,080,961 total
Conversion
IsoPlexis Corp
Common Stock
2021-10-12+1,040,048→ 1,080,961 total
Conversion
IsoPlexis Corp
Common Stock
2021-10-12+6,304,192→ 6,727,570 total
Conversion
DICE Therapeutics, Inc.
Series C Convertible Preferred Stock
2021-09-17−867,687→ 0 total
Conversion
DICE Therapeutics, Inc.
Common Stock
2021-09-17+454,796→ 3,057,871 total
Conversion
DICE Therapeutics, Inc.
Series C-1 Convertible Preferred Stock
2021-09-17−454,796→ 0 total
Conversion
DICE Therapeutics, Inc.
Common Stock
2021-09-17+2,603,075→ 2,603,075 total
Purchase
DICE Therapeutics, Inc.
Common Stock
2021-09-17$17.00/sh+235,000→ 3,292,871 total
Conversion
DICE Therapeutics, Inc.
Series B Convertible Preferred Stock
2021-09-17−1,735,388→ 0 total
Conversion
Telesis Bio Inc.
Series A-1 Preferred Stock
2021-06-22−4,160,529→ 0 total
Purchase
Telesis Bio Inc.
Common Stock
2021-06-22$16.00/sh+468,750→ 9,844,130 total
Conversion
Telesis Bio Inc.
Common Stock
2021-06-22+9,375,380→ 9,375,380 total
Conversion
Telesis Bio Inc.
Series A Preferred Stock
2021-06-22−5,214,851→ 0 total

Companies

Recent Filings

Address

C/O NORTHPOND VENTURES 7500 OLD GEORGETOWN ROAD, SUITE 850

BETHESDA, MD, 20814

View on SEC.gov